Search Results - Ebru Demirci
- Showing 1 - 2 results of 2
-
1
Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU by Ebru Demirci, Grace Omes‐Smit, Alex Zwiers
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
A detailed analysis of expedited regulatory review time of marketing authorization applications for new anticancer drugs in the US and EU by Fabiany da Costa Gonçalves, Ebru Demirci, Alex Zwiers
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book